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Background
Left ventricular (LV) ejection fraction (EF) is important
predictor of clinical outcomes in patients with non-
ischemic cardiomyopathy (NICMP). With the advent of
gadolinium-enhanced cardiac magnetic resonance ima-
ging (CMR), it has now become possible to discern the
presence of myocardial replacement fibrosis (RF) with a
high level of accuracy. The aim of our study is to investi-
gate the predictive value of RF in patients with NICMP.
Methods
A prospective, longitudinal study of the prognostic value
of replacement fibrosis in a cohort of 240 consecutive
patients with NICMP was performed. The presence and
extent of late gadolinium enhancement (LGE) in tissue,
which is assumed to represent replacement fibrosis, was
determined by visual inspection using the American
Heart Association 17-segment model without knowledge
of any other clinical factors. Cine-CMR images were also
analyzed to calculate functional parameters of the heart
(ejection fraction, volumes, etc.). Baseline characteristics
were collected and outcome data and clinical events were
determined by telephone follow-up, chart review and/or
the social security death index.
Results
The age of our patients was 55.5 ± 15.9 years while males
comprised 60% of the population. LVEF was 33.4 ± 10.5%.
The median (interquartile range) left ventricular fibrosis
extent was 2.0%. There were 42 (17.5%) patients with
significant fibrosis (SiF; left ventricular fibrosis > 5%).
Patients with SiF were more likely to have history of dysli-
pidemia (p = 0.005) and smoking (p = 0.004). There were
32 (13%) deaths during follow-up period. Patients with SiF
had more death than those without (26%.vs.11%, p =
0.007). Patients who died were more likely to have a his-
tory of diabetes (p = 0.007). Both presence of SiF and
fibrosis extent were independent predictors for all-cause
mortality (p = 0.006 and p < 0.001 respectively). Other
independent predictors were history of diabetes (p =
0.006) and BMI (p = 0.006). As secondary clinical out-
come, composite of all-cause mortality and heart trans-
plant occurred in 15.4% of the cohort. There were
significantly more events in patients with SiF than those
without SiF (29%.vs.13%, p = 0.009). Prevalence of history
of diabetes, extent of LV fibrosis and LVSV were signifi-
cantly higher in patients who had reached the secondary
outcomes compared to those who did not (p = 0.007,
0.035, 0.042 respectively).
Conclusions
In patients with NICMP, the presence of scar is an inde-
pendent risk factor for all-cause mortality and the extent
of scar portends a worse prognosis. LGE on CMR provides
useful diagnostic information in addition to traditional risk
factors of mortality in heart failure and may be relevant to
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